Effect of size of bioactive glass nanoparticles on mesenchymal stem cell proliferation for dental and orthopedic applications

被引:69
作者
Ajita, J. [1 ]
Saravanan, S. [1 ]
Selvamurugan, N. [1 ]
机构
[1] SRM Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur 603203, Tamil Nadu, India
来源
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS | 2015年 / 53卷
关键词
Bioactive glass nanoparticles; Size; Cell proliferation; Cyclins; ERK activation; IN-VITRO; SCAFFOLDS; CALCIUM; BIOGLASS(R); CYCLINS; SILICA;
D O I
10.1016/j.msec.2015.04.041
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
082905 [生物质能源与材料]; 100103 [病原生物学];
摘要
Bioactive glass nanoparticles (nanostructured bioglass ceramics or nBGs) have been widely employed as a filler material for bone tissue regeneration. The physical properties of nBG particles govern their biological actions. In this study, the impact of the size of nBG particles on mouse mesenchymal stem cell (mMSC) proliferation was investigated. Three different sizes of nBG particles were prepared via the sol-gel method with varying concentrations of the surfactant and polyethylene glycol (PEG), and the particles were characterized. Increased concentrations of PEG decreased the size of nBG particles (nBG-1: 74.7 +/- 0.62 nm, nBG-2: 43.25 +/- 1.5 nm, and nBG-3: 37.6 +/- 0.81 nm). All three nBGs were non-toxic at a concentration of 20 mg/rnL. Increased proliferation was observed in mMSCs treated with smaller nBG particles. Differential mRNA expression of cyclin A2, B2, D1, and El genes induced by nBG particles was noticed in the mMSCs. nBG-1 and nBG-3 particles promoted cells in the G0/G1 phase to enter the S and G2/M phases. nBG particles activated ERK, but prolonged activation was achieved with nBG-3 particles. Among the prepared nBG particles, nBG-3 particles showed enhanced mMSC proliferation via the sustained activation of ERKs, upregulation of cyclin gene(s) expression, and promotion of cell transition from the G0/G1 phase to the S and G2/M phases. Thus, this study indicates that small nBG particles have clinical applications in dental and bone treatments as fillers or bone-tissue bond forming materials. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:142 / 149
页数:8
相关论文
共 29 条
[1]
Characterization of some bioglass-ceramics [J].
ElBatal, HA ;
Azooz, MA ;
Khalil, EMA ;
Monem, AS ;
Hamdy, YM .
MATERIALS CHEMISTRY AND PHYSICS, 2003, 80 (03) :599-609
[2]
GRANA X, 1995, ONCOGENE, V11, P211
[3]
Hamlekhan A, 2010, ADV COMPOS LETT, V19, P123
[4]
Hench LL., 1996, LIFE CHEM REP, V13, P187
[5]
Hench LL, 1990, HDB BIOACTIVE CERAMI
[6]
Preparation and in vitro characterization of novel bioactive glass ceramic nanoparticles [J].
Hong, Zhongkui ;
Reis, Rui L. ;
Mano, Joao F. .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2009, 88A (02) :304-313
[7]
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics [J].
Hoppe, Alexander ;
Gueldal, Nusret S. ;
Boccaccini, Aldo R. .
BIOMATERIALS, 2011, 32 (11) :2757-2774
[8]
Cyclins and cell cycle checkpoints [J].
Johnson, DG ;
Walker, CL .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :295-312
[9]
pH-compensation effect of bioactive inorganic fillers on the degradation of PLGA [J].
Li, HY ;
Chang, J .
COMPOSITES SCIENCE AND TECHNOLOGY, 2005, 65 (14) :2226-2232
[10]
Nanostructured scaffolds for bone tissue engineering [J].
Li, Xiaoming ;
Wang, Lu ;
Fan, Yubo ;
Feng, Qingling ;
Cui, Fu-Zhai ;
Watari, Fumio .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2013, 101 (08) :2424-2435